ACTRN12611000448943已完成不适用
A Prospective, Randomized, Double-Blind Trial To Evaluate The Role of Topical Anaesthetics In Controlling Pain After Corneal Abrasion In The Emergency Department
Southland Hospital0 个研究点目标入组 180 人开始时间: 2011年5月3日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Inclusion criteria includes any simple acute corneal abrasions from mechanical trauma, ultraviolet light, foreign body, or from removal of foreign body by the physician.
- •For patients to be eligible for this study they also need to have presented to the Emergency Department within 36 hours of their initial injury.
排除标准
- •Exclusion criteria. There are a number of reasons that subjects may be excluded from participating in this study.
- •If patients present to the Emergency Department more that 36 hours after their initial injury they will be excluded as the majority of corneal abrasion healing will already have occured.
- •If patients are under the age of 18.
- •If patients have had previous eye surgery or cataracts.
- •If patients wear contact lenses or if their injury was caused from contact lens wear.
- •If patients are unable to give informed consent.
- •If patients are suffering from infectious or chemical conjunctivitis.
- •If the patients eye contains a grossly contaminated foreign body.
- •If the patient is suffering from an ocular infection.
- •If the patient currently has herpes keratitis.
- •If the patient is allergic to Tetracaine or similar medication classes.
- •If the injury requires urgent ophthalmologic evaluation (e.g. penetrating eye injuries, large or complicated corneal abrasions or injuries causing a significant disruption of vision).
研究者
相似试验
进行中（未招募）
不适用
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 5 Days Versus Placebo Versus Telithromycin In the Treatment of Acute Exacerbation of Chronic Bronchitis - NDAcute Exacerbation of Chronic BronchitisMedDRA version: 9.1Level: LLTClassification code 10006458Term: Bronchitis chronicEUCTR2006-003944-42-ITREPLIDYNE, INC.700
进行中（未招募）
不适用
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 5 Days Versus Placebo in the Treatment of Acute Exacerbation of Chronic Bronchitis”EUCTR2006-003944-42-LVReplidyne, Inc.611
进行中（未招募）
不适用
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 10 Days Versus Clarithromycin in the Treatment of Community-Acquired Pneumonia”Community-acquired pneumonia. This disease can be defined as an acute lower respiratory tract infection not acquired in a hospital or a long-term care facility.MedDRA version: 9.1Level: LLTClassification code 10010120Term: Community acquired pneumoniaEUCTR2007-003854-28-DEReplidyne, Inc.770
进行中（未招募）
不适用
Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 5 Days Versus Placebo in the Treatment of Acute Exacerbation of Chronic Bronchitis”acute exacerbation of chronic bronchitisMedDRA version: 9.1Level: LLTClassification code 10000744Term: Acute exacerbation of chronic bronchitis NOSEUCTR2006-003944-42-BGReplidyne, Inc.611
已完成
不适用
TAP Block Study - A Prospective, Double-blind Randomised Trial to Assess the Efficacy of Ultrasound Guided Transversus Abdominis Plane Blocks Using Ropivacaine in Patients Undergoing Laparoscopic Abdominal Surgery.ACTRN12611000727943John Hunter Hospital140